The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

RFK Jr.’s views on vaccine safety have sparked debate, with some experts saying that his comments are misleading.

Vaxart, Inc. (NASDAQ:VXRT), a biotechnology company specializing in the development of oral recombinant vaccines with a market capitalization of approximately $159 million, announced on Monday an ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

A potential new cancer vaccine could be on the horizon as a study has yielded “exciting” results. Scientists have revealed ...

Scientists are encouraged by findings that jab can eliminate tumour in patients with stage three or four kidney cancer ...

Ugandan authorities have begun a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one person in ...

Uganda has begun a clinical trial of a vaccine against the Sudan strain of Ebola following an outbreak that has killed one ...

Ugandan Health Authorities Are Set to Begin an Ebola Vaccine Trial After New Outbreak Kills a Nurse KAMPALA, Uganda (AP) — ...

Ugandan authorities launched a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one nurse in the ...